Sign in

    Lishan Aklog

    Chairman and Chief Executive Officer at Lucid Diagnostics Inc
    Board
    Since January 17, 2022
    Age
    59 years
    Education
    Holds an A.B. in Physics, magna cum laude, from Harvard University and an M.D. in molecular genetics, cum laude, from Harvard Medical School.
    Tenure
    Has served as Chairman and Chief Executive Officer of LUCD since the consummation of the company's initial public offering, previously holding the role of Executive Chairman from its inception.

    Also at Lucid Diagnostics Inc

    DMM
    Dennis M. McGrath
    Chief Financial Officer
    MAG
    Michael A. Gordon
    General Counsel and Secretary
    SMO
    Shaun M. O’Neil
    President and Chief Operating Officer

    About

    Lishan Aklog, M.D., is a seasoned medical professional and entrepreneur with extensive experience in the life sciences industry. He has demonstrated leadership in multiple high-profile roles, exemplified by his current position as Chairman and Chief Executive Officer of LUCD, a role he assumed at the time of the company's initial public offering.

    Prior to his tenure as CEO, he served as Executive Chairman of LUCD from its inception, showcasing his longstanding commitment to the company's growth and strategic vision. In addition, he has played pivotal roles at PAVmed Inc. and Veris Health Inc., further highlighting his multifaceted executive experience in the healthcare sector.

    Complementing his executive leadership, Dr. Aklog brings a strong academic and clinical foundation, having held several professorships and innovated in cardiac surgery. His career reflects a blend of clinical excellence and technological innovation, making significant contributions as an inventor on multiple patents and as a consultant to leading medical technology companies.

    $LUCD Performance Under Lishan Aklog

    Past Roles

    OrganizationRoleDate RangeDetails
    Contrafect Inc. Board of Directors & Audit Committee Member June 2020 – December 2023 Former board service
    Viveon Health Acquisition Corp. Board of Directors & Chair of Audit Committee September 2020 – April 2021 Former board leadership role
    Lucid Diagnostics Inc. (LUCD) Executive Chairman From Inception – IPO Transitioned to Chairman & CEO after IPO
    Vortex Medical Inc. Chairman and Chief Technology Officer 2008 – October 2012 Acquired by AngioDynamics Inc.
    Biomet Inc. (Consultant) Consultant 2009 – 2017 Engagement as consultant
    Atricure Inc. (Consultant) Consultant 2007 – 2016 Engagement as consultant
    AngioDynamics Inc. (Consultant) Consultant 2012 – 2016 Engagement as consultant
    On-X Life Technologies Inc. (Consultant) Consultant 2009 – 2012 Engagement as consultant
    Edward Lifesciences Corp. (Consultant) Consultant 2007 – 2012 Engagement as consultant
    Mount Sinai Medical Center Assistant Professor of Cardiothoracic Surgery, Associate Chief of Cardiac Surgery, Director of Minimally Invasive Cardiac Surgery, Surgical Director of the Cardiothoracic Intensive Care Unit, Associate Director of the Thoracic Surgery Residency Program 2006 – 2012 Academic leadership role
    St. Joseph’s Hospital and Medical Center’s Heart and Lung Institute Associate Professor of Surgery, Chief of Cardiovascular Surgery, Chair of The Cardiovascular Center 2006 – 2012 Academic and clinical leadership
    Harvard Medical School / Brigham and Women’s Hospital Assistant Professor of Surgery, Director of the Cardiac Surgery Research Laboratory, Attending Cardiac Surgeon 1999 – 2002 Academic and clinical role
    Scientific Advisory Boards (Medtronic Inc., St. Jude Medical Inc., Guidant Cardiac Surgery, Cardiovations) Board Member N/A Previously served on these advisory boards

    External Roles

    OrganizationRoleDate RangeDetails
    Veris Health Inc. Executive Chairman Since May 2021 – Present Majority-owned subsidiary of PAVmed
    Advanced Medical Technology Association Board of Directors Since February 2021 – Present Leading medical technology trade association
    PAVmed Inc. Chairman and Chief Executive Officer Since June 2014 – Present Parent company of LUCD
    Pavilion Medical Innovations Co-founding Partner Since 2009 – Present Venture-backed medical device incubator
    Pavilion Holdings Group Co-founding Partner Since 2007 – Present Medical device holding company

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Salary$300,000 Annual (2024)Base salary as per employment agreement
    Stock Awards$412,000 2024 (Grant Date)Restricted stock award valued under ASC 718
    Option Awards$0 2024No stock options granted
    All Other Compensation$0 2024No additional compensation provided

    Performance Compensation

    Data from  FY 2024

    Performance Bonus

    ComponentTarget AmountActual AwardedEvaluation PeriodPerformance Metrics/Thresholds
    Cash Bonus$300,000 (100% of base salary) $02024No detailed performance metrics provided

    Equity Performance Component

    ComponentNumber of SharesGrant DateVesting ScheduleAdditional Conditions
    Restricted Stock Award400,000 shares May 7, 2024Vests May 20, 2026; accelerated upon termination for "good reason," termination without "cause," or change of control Grant date fair value of $412,000 ; grant date stock price not provided